You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 10, October 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (75)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Epilepsy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Homocysteine and Neurologic Disease

Ramon Diaz-Arrastia, MD, PhD

Arch Neurol. 2000;57:1422-1427.

Over the last 10 years, there has been an explosion of interest in homocysteine, a sulfur-containing amino acid that occupies a central location in the metabolic pathways of thiol compounds. This interest is primarily because of the realization that hyperhomocysteinemia is an important risk factor for vascular disease, including stroke, independent of long-recognized factors such as hyperlipidemia, hypertension, diabetes mellitus, and smoking. Since elevated homocysteine levels can often be normalized by supplementing the diet with folic acid (folate), pyridoxine hydrochloride (vitamin B6), and cyanocobalamin (vitamin B12), these observations raise the exciting possibility that this inexpensive and well-tolerated therapy may be effective in decreasing the incidence of vascular disease. In addition to its association with cerebrovascular disease, homocysteine may play a role in neurodegenerative disorders, even if only as a marker of functional vitamin B12 deficiency. Homocysteine is also important to neurologists since most anticonvulsants raise homocysteine levels, an effect that may explain the teratogenic effects of these drugs. Practical knowledge concerning some details of homocysteine metabolism, the diagnosis of hyperhomocysteinemia, and the use of polyvitamin therapy to lower homocysteine levels will be increasingly important in the treatment of patients with neurologic disease.


From the Department of Neurology, University of Texas Southwestern Medical Center, Dallas.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2000;57(10):1535-1537.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Role of micronutrients in the periconceptional period
Cetin et al.
Hum Reprod Update 2009;0:dmp025v1-dmp025.
ABSTRACT | FULL TEXT  

Homocysteine Levels in Epileptic Children Receiving Antiepileptic Drugs
Kurul et al.
J Child Neurol 2007;22:1389-1392.
ABSTRACT  

Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease.
de Lau et al.
Neurology 2006;67:315-318.
ABSTRACT | FULL TEXT  

Folate Intake and Risk of Stroke Among Women
Al-Delaimy et al.
Stroke 2004;35:1259-1263.
ABSTRACT | FULL TEXT  

Levodopa Elevates Homocysteine: Is This a Problem?
O'Suilleabhain and Diaz-Arrastia
Arch Neurol 2004;61:633-634.
FULL TEXT  

Epilepsy and Women's Health: Family Planning, Bone Health, Menopause, and Menstrual-Related Seizures
Liporace and D'Abreu
Mayo Clin Proc. 2003;78:497-506.
ABSTRACT  

Elevated Plasma Homocysteine Levels in Patients Treated With Levodopa: Association With Vascular Disease
Rogers et al.
Arch Neurol 2003;60:59-64.
ABSTRACT | FULL TEXT  

Fibrillin-2 Defects Impair Elastic Fiber Assembly in a Homocysteinemic Chick Model
Hill et al.
J. Nutr. 2002;132:2143-2150.
ABSTRACT | FULL TEXT  

Relationship between plasma homocysteine levels and brain atrophy in healthy elderly individuals
Sachdev et al.
Neurology 2002;58:1539-1541.
ABSTRACT | FULL TEXT  

Plasma Homocysteine Levels, Cerebrovascular Risk Factors, and Cerebral White Matter Changes (Leukoaraiosis) in Patients With Alzheimer Disease
Hogervorst et al.
Arch Neurol 2002;59:787-793.
ABSTRACT | FULL TEXT  

Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy: An Invited Review
Gorelick
Stroke 2002;33:862-875.
ABSTRACT | FULL TEXT  

Limits of the Genetic Revolution
Scheuerle
Arch Pediatr Adolesc Med 2001;155:1204-1209.
ABSTRACT | FULL TEXT  

Vitamin B12 and folate in relation to the development of Alzheimer's disease
Wang et al.
Neurology 2001;56:1188-1194.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.